Phase 1 Study of Stereotactic Body Radiation Therapy for Liver Tumors Utilizing an MRI-Guided Tri-Co Teletherapy System
P. Lee, Amar U. Kishan(University of California, Los Angeles), Argin G. Mikaeilian(University of California, Los Angeles), Mitchell Kamrava(Cedars-Sinai Medical Center), Minsong Cao(Ronald Reagan UCLA Medical Center), Nzhde Agazaryan(University of California, Los Angeles), Michael L. Steinberg(University of California, Los Angeles), Daniel A. Low(University of California, Los Angeles), James Lamb(University of California, Los Angeles), José Hernández(University of California, Los Angeles), David H. Thomas(Conservation Leadership Programme)
International Journal of Radiation Oncology*Biology*Physics
September 23, 2017
Cited by 0
Related Papers
Tolerance limits and methodologies for<scp>IMRT</scp>measurement‐based verification<scp>QA</scp>:<i>Recommendations of<scp>AAPM</scp>Task Group No. 218</i>
|Medical Physics|2018|1k
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
|Practical Radiation Oncology|2021|261
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
|Advances in Radiation Oncology|2018|161